<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00737698</url>
  </required_header>
  <id_info>
    <org_study_id>rMS v exercise in COPD</org_study_id>
    <nct_id>NCT00737698</nct_id>
  </id_info>
  <brief_title>Comparison of Repetitive Magnetic Stimulation (rMS) and Exercise Versus no Active Treatment on Quadriceps Function in Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <official_title>Is the Anaerobic Quadriceps Muscle Phenotype in Chronic Obstructive Pulmonary Disease Mediated by Reduced Muscle Concentrations of Peroxisome Proliferator-Activated Receptors Alpha and Delta?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wellcome Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Magstim Company, Whitland, Wales</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background Chronic Obstructive Pulmonary Disease (COPD) patients develop leg weakness and a
      reduced walking capacity, due to reduced leg muscle oxygen-utilising capacity (OUC). Animal
      experiments indicate that low muscle levels of Peroxisome Proliferator-Activated Receptors
      (PPAR) cause the reduced muscle OUC.

      Aims

      In COPD patients, investigate whether:

        1. reduced muscle PPAR levels cause reduced leg muscle OUC, by investigating a correlation
           between these in muscle samples (Study 1).

        2. training increases muscle PPAR levels in proportion to increases in OUC, as should occur
           if PPARs control OUC (Study 2).

        3. muscle PPAR levels and walking capacity correlate (Study 1 and 2).

      3. the new technique of repetitive stimulation of the nerve to the leg with a magnet (rMS)
      improves muscle OUC (Study 2).

      Study 1 Leg weakness and walking ability are assessed in 75 patients, then a leg muscle
      sample is taken to measure PPARs and OUC.

      Study 2 60 Study 1 patients have either cardiovascular training, rMS, or no training, for 8
      weeks, then are re-studied as in Study 1.

      Importance If reduced PPAR levels correspond with leg weakness, medicines can be developed to
      target these receptors and treat weakness. If rMS is effective, it can be offered to
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in muscle Peroxisome Proliferator-Activated Receptor mRNA and protein levels</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in muscle strength and endurance, and exercise performance</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Repetitive magnetic stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No active treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Physiotherapist-supervised exercise course (endurance and resistance exercises) for 2 hours twice a week for 8 weeks</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Repetitive magnetic stimulation</intervention_name>
    <description>Repetitive magnetic stimulation of the intramuscular branches of the femoral nerve for 3 hours twice a week for 8 weeks</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic Obstructive Pulmonary Disease

        Exclusion Criteria:

          -  Cardiac failure

          -  Renal failure

          -  Liver failure

          -  Diabetes mellitus

          -  Systemic inflammatory diseases eg Rheumatoid arthritis, SLE

          -  Warfarin, coagulation problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael I Polkey, MBBS FRCP PhD</last_name>
    <role>Study Director</role>
    <affiliation>Royal Brompton Hospital/Imperial College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samantha A Sathyapala, MA BMBCH MRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Respiratory Muscle Lab, Royal Brompton Hospital, Fulham Road</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2008</study_first_submitted>
  <study_first_submitted_qc>August 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2008</study_first_posted>
  <last_update_submitted>February 17, 2016</last_update_submitted>
  <last_update_submitted_qc>February 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Imperial College London</investigator_affiliation>
    <investigator_full_name>Amanda Sathyapala</investigator_full_name>
    <investigator_title>Wellcome Trust Clinical Research Fellow</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>exercise</keyword>
  <keyword>repetitive magnetic stimulation</keyword>
  <keyword>quadriceps strength</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

